Robert Blee
Internal Medicine · Washington, DCNPI 1730193301
Payments from drug & device makers
Across 124 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$442
- Novo Nordisk$295
- Amgen$264
- AbbVie$212
- Bausch Health US, LLC$174
- AstraZeneca$120
- plus $942 from 26 others
What the payments were for
- Food & beverage$2,450100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 22 | $442 |
| Novo Nordisk | 16 | $295 |
| Amgen(2 entities) | 13 | $264 |
| AbbVie(2 entities) | 9 | $212 |
| Bausch Health US, LLC | 8 | $174 |
| AstraZeneca | 6 | $120 |
| Biohaven Pharmaceuticals, Inc. | 4 | $85 |
| Merck | 5 | $80 |
| Kowa Pharmaceuticals America, Inc. | 4 | $78 |
| Esperion Therapeutics, Inc. | 3 | $61 |
| Amarin Pharma, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Bayer | 2 | $43 |
| Eisai Inc. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| Fidia Pharma USA Inc. | 2 | $40 |
| Radius Health, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Lilly USA, LLC | 1 | $22 |
| GSK | 1 | $20 |
| Novartis | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Genentech USA, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,450 in reported general payments places this provider in the 85th percentile of 645 internal medicine providers in District of Columbia.
See all internal medicine providers in District of Columbia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $26,679 |
| JardianceEmpagliflozin | 13 | $20,654 |
| XareltoRivaroxaban | 22 | $19,694 |
| FarxigaDapagliflozin Propanediol | 24 | $19,189 |
| OzempicSemaglutide | 17 | $12,410 |
| VascepaIcosapent Ethyl | 17 | $6,170 |
| Febuxostat | 15 | $3,986 |
| SynthroidLevothyroxine Sodium | 26 | $2,233 |
| Rosuvastatin Calcium | 86 | $1,760 |
| Atorvastatin Calcium | 118 | $1,506 |
| Nebivolol Hcl | 21 | $1,089 |
| Finasteride | 46 | $961 |
| Metoprolol Succinate | 52 | $858 |
| Esomeprazole Magnesium | 14 | $717 |
| Duloxetine Hcl | 28 | $708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $442 | $26,67927 claims |
| Boehringer IngelheimJardiance | $19 | $20,65413 claims |
| Johnson & JohnsonXarelto | $12 | $19,69422 claims |
| AstraZenecaFarxiga | $120 | $19,18924 claims |
| Novo NordiskOzempic | $295 | $12,41017 claims |
| AbbVieSynthroid | $212 | $2,23326 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $63158 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 645 internal medicine providers in District of Columbia.
Other internal medicine in Washington
- Federico AschWashington$4.6M
- Geoffrey GibneyWashington$2.3M
- Nnemdi Kamanu EliasWashington$939K
- Andrea SingerWashington$930K
- Kathryn SowerwineWashington$831K
- Douglas WardWashington$454K
- Ida BergstromWashington$295K
- Miriam CameronWashington$290K
- Bruce RashbaumWashington$265K
- Kevin GriffithsWashington$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.